The Foundational Research: Ziobrowski et al.
The academic debate over whether Congress members enjoy a trading advantage began in earnest with a 2004 paper published in the Journal of Financial and Quantitative Analysis. Researchers Alan Ziobrowski, James Boyd, Ping Cheng, and Charles Ziobrowski at Georgia State University analyzed stock transactions reported by United States senators between 1993 and 1998. Their methodology was straightforward: they compiled a database of disclosed trades, constructed hypothetical portfolios based on those trades, and compared the performance against broad market benchmarks.
The results were dramatic. Senate portfolios outperformed the overall stock market by approximately 12 percentage points per year. This is not a marginal edge — it is a level of outperformance that exceeds what the vast majority of professional money managers achieve. For context, Warren Buffett’s Berkshire Hathaway has compounded returns at roughly 20% per year over decades, which is widely regarded as one of the greatest investment track records in history. Senators, as a group, were generating alpha that would make most hedge fund managers envious.
The 2004 study focused exclusively on senators. In 2011, the same research team published a companion study examining House members during the same period. The House study found outperformance of approximately 6 percentage points per year — meaningful but roughly half the Senate’s advantage.
The gap between chambers was itself a significant finding. Senators serve on fewer committees but those committees tend to have broader jurisdiction. They also serve six-year terms, giving them longer time horizons for policy-related trades. The Senate is also a smaller body — 100 members versus 435 in the House — meaning individual senators wield more influence over legislative outcomes. All of these factors could plausibly contribute to a stronger information advantage.
Subsequent Academic Work
The Ziobrowski findings sparked a wave of follow-up research. While some subsequent studies found smaller magnitudes of outperformance, the general finding has proven remarkably durable. A 2013 paper by Eggers and Hainmueller reexamined the data using different methodological approaches and found more modest results, but still documented statistically significant outperformance in certain subgroups — particularly among members with relevant committee assignments.
Research published in 2020 by scholars at the University of Michigan focused specifically on defense-sector trading by members of the Senate and House Armed Services Committees. The study found that committee members earned abnormal returns on defense stocks during periods when significant procurement and spending decisions were being made. The timing of purchases clustered suspiciously around periods when the committee was actively deliberating on contracts worth billions of dollars.
A separate body of research has examined pharmaceutical and healthcare trading by members of health-related committees. These studies have found similar patterns: members who sit on the Senate HELP Committee (Health, Education, Labor, and Pensions), the Senate Finance Committee (which oversees Medicare and Medicaid), or the House Energy and Commerce Committee show stronger performance in healthcare stocks compared to their trades in unrelated sectors.
Work by Trader and colleagues in 2024 used the post-STOCK Act era (2013-2023) as their dataset and found that while the aggregate advantage had diminished somewhat — possibly due to increased public scrutiny — it had not disappeared. Members who traded in sectors aligned with their committee work continued to generate returns that were statistically difficult to explain by chance alone.
The Committee Correlation
Perhaps the strongest evidence for a genuine information advantage — as opposed to simple wealth or luck — is the committee correlation. If congressional outperformance were simply the result of being wealthy, well-advised individuals, you would expect it to be relatively uniform across all sectors and all members. Instead, the data shows a striking pattern: members perform best in the specific sectors over which they have legislative jurisdiction.
This finding is difficult to explain without reference to information advantages. A member of the Senate Banking Committee who outperforms in financial stocks but not in healthcare stocks is unlikely to be benefiting from general wealth or superior financial advice — those factors would produce uniform outperformance. The sector-specific nature of the advantage points toward the committee room as the source.
You can explore these patterns on our leaderboard and trends pages, which allow you to filter by member, sector, and time period. The committee alignment of individual members’ trading activity is often the most revealing lens through which to analyze the data.
Some of the most striking examples of committee-correlated trading have involved members who purchased stocks shortly before their committees took action that benefited those companies. During the early weeks of the COVID-19 pandemic in January and February 2020, several senators who received classified briefings about the virus threat sold significant stock positions before the market’s dramatic decline. While the Department of Justice investigated and ultimately did not bring charges, the episode illustrated how committee access to non-public information could translate into trading advantages.
Comparing to the S&P 500
One of the most straightforward ways to assess congressional trading performance is to compare it against the S&P 500 index, the most commonly used benchmark for U.S. stock market performance. Over long periods, the S&P 500 has returned approximately 10% per year including dividends. The vast majority of professional investors — roughly 80-90% over any given 15-year period, according to SPIVA data — fail to beat this benchmark after fees.
Against this backdrop, the Ziobrowski finding of 12% annual outperformance by senators is extraordinary. Even the more modest findings of subsequent studies — suggesting outperformance in the range of 3-6% — place congressional traders well above the average professional fund manager.
It is worth noting that these comparisons may actually understate the advantage in some cases. Congressional disclosure data uses dollar ranges rather than exact amounts, forcing researchers to use midpoint estimates. If members tend to cluster their trades at the higher end of each range (which would be rational for traders with high conviction), the actual performance could be better than what midpoint-based analysis suggests.
Conversely, not all members outperform. The aggregate statistics are pulled upward by strong performers and pulled downward by poor ones. When you look at the distribution, some members consistently generate alpha while others consistently underperform. The CongressFlow leaderboard makes these individual differences visible, allowing you to distinguish between members whose trades consistently beat the market and those whose trades lag.
Specific Examples of Well-Timed Trades
While academic studies establish the statistical case for a congressional trading advantage, specific examples bring the issue to life and illustrate how the advantage can manifest in practice.
In January 2020, Senator Richard Burr, then chairman of the Senate Intelligence Committee, sold between $628,000 and $1.72 million in stock holdings on February 13, 2020, shortly after attending classified briefings about the coming COVID-19 pandemic. The broader market did not begin its sharp decline until February 20. Burr’s sales were later investigated by the DOJ and SEC, though no charges were filed. He stepped down as Intelligence Committee chairman during the investigation.
Around the same time, Senator Kelly Loeffler — who was married to the chairman of the New York Stock Exchange — sold millions in stock holdings beginning on January 24, 2020, the same day the Senate received a closed-door briefing from health officials about COVID-19. She simultaneously purchased shares of Citrix, a remote-work technology company that stood to benefit from a pandemic. The DOJ investigated and cleared Loeffler, but the trades became a major issue in her 2020 election campaign.
More routine examples are visible in the disclosure data every quarter. Members of the House Energy and Commerce Committee buying shares of companies that later benefit from energy legislation. Members of the Senate Finance Committee selling pharmaceutical stocks before drug pricing regulations are announced. Members of the Armed Services Committee accumulating positions in defense contractors before budget increases are approved. Individually, any one of these trades could be coincidental. In aggregate, the pattern is harder to dismiss.
The Counter-Arguments
Intellectual honesty requires engaging with the counter-arguments to the congressional trading advantage thesis. Several legitimate critiques deserve consideration:
- Survivorship bias: Members who lose money trading may be less likely to run for reelection or may exit office for other reasons, leaving a pool of survivors who were disproportionately successful. This could inflate the apparent average performance of sitting members.
- Wealth effects: The median net worth of a U.S. senator is several million dollars — far above the national median. Wealthy individuals tend to have access to better financial advisors, more sophisticated investment strategies, and greater diversification. Some of the outperformance may reflect the advantages of wealth rather than legislative access to information.
- Selection effects: People who run for Congress may be, on average, more informed about economic and business conditions than the general population. If this is true, some of their trading success may reflect general expertise rather than specific inside information.
- Methodological debates: Different studies using different time periods, benchmarks, and statistical methods produce somewhat different results. Critics argue that the most dramatic findings (like the 12% annual outperformance) may reflect specific methodological choices rather than robust, generalizable patterns.
- Financial advisor delegation: Some members claim that their financial advisors make trading decisions independently, without the member’s input. If this is true for a significant portion of trades, the connection between legislative information and trading outcomes is weaker than it appears.
These are serious objections, and they prevent any responsible analyst from claiming with certainty that every congressional trade is information-driven. However, none of them fully explains the committee-specific pattern of outperformance. Wealth effects and survivorship bias should produce uniform outperformance across sectors, not the sector-specific advantage that the data consistently shows.
What This Means for You
The evidence for a congressional trading advantage is strong but not absolute. The most prudent interpretation is that members of Congress, as a group, trade better than the average investor — and that the advantage is concentrated among members who trade in sectors related to their committee work.
For regular investors, this means congressional trade data is worth monitoring — not as a get-rich-quick scheme, but as a supplementary research tool that can provide insights into policy direction and sector sentiment. The case for why these trades matter extends beyond investment returns to encompass government accountability and democratic transparency.
Whether you are interested in the investment implications, the ethical dimensions, or both, the starting point is the same: explore the data. Browse the leaderboard to see which members are performing best, examine the trends to spot aggregate patterns, and read about the difference between congressional trading and insider trading to understand the legal framework that allows this activity to continue.
